摘要
目的测定AECOPD患者雾化吸入布地奈德前后诱导痰中TNF-α和sTNF-R55、sTNF-R75水平,阐明吸入布地奈德是否影响TNF-α系统。方法检测57例AECOPD患者(吸入组28例,常规组29例)入院时和治疗第7天诱导痰中TNF-α和sTNF-R55、sTNF-R75水平及肺功能的变化。结果吸入组治疗后FEV1、FEV1%、FEV1/FVC、PaO2的改善优于常规组,其中FEV1、FEV1%的改善有显著性。吸入组诱导痰中TNF-α、sTNF-R55和sTNF-R75水平显著低于治疗前。常规组诱导痰中TNF-α、sTNF-R55和sTNF-R75水平低于治疗前,其中TNF-α和sTNF-R75的差异有显著性。治疗后吸入组诱导痰中TNF-α、sTNF-R55和sTNF-R75的水平较常规组显著降低。结论吸入布地奈德利于TNF-α、sTNFR水平降低,有助于TNF-α/sTNF-R恢复平衡,减轻气道炎症反应,改善肺功能。
Objective To elucidate the influence of budesonide on TNF-α system by detecting the levels of TNF-α,sTNF-R55 and sTNF-R75 in induced sputum of patients with AECOPD before and after the treatment.Methods 57 patients with AECOPD were randomly divided into the inhalation group(28 cases) and the routine group(29 cases).The routine group received only standard treatment while the inhalation group received budesonide.The lung function and the levels of TNF-α,sTNF-R55 and sTNF-R75 in the induced sputum were measured and analyzed before and 6 days after the treatment.Results After the treatment,the improvement of FEV1,FEV1%,FEV1/ FVC and PaO2 was more pronounced in the inhalation group than in the routine group(P〈0.05).The levels of TNF-α,sTNF-R55 and sTNF-R75 decreased obviously after the treatment in the inhalation group(P〈0.05).Conclusion The inhalation of budesonide can reduce the levels of TNF-α and sTNFR,rebalance the system of TNF-α / sTNF-R,reduce airway inflammation and improve the lung function in the treatment of AECOPD patients.
出处
《临床肺科杂志》
2013年第8期1394-1396,共3页
Journal of Clinical Pulmonary Medicine